Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Dividend Payout Ratio?

Laboratorios Farmaceuticos Rovi's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio or its related term are showing as below:

XMAD:ROVI' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.3 Max: 0.52
Current: 0.49

During the past 13 years, the highest Dividend Payout Ratio of Laboratorios Farmaceuticos Rovi was 0.52. The lowest was 0.11. And the median was 0.30.

XMAD:ROVI's Dividend Payout Ratio is ranked worse than
55.81% of 129 companies
in the Biotechnology industry
Industry Median: 0.44 vs XMAD:ROVI: 0.49

As of today (2024-05-16), the Dividend Yield % of Laboratorios Farmaceuticos Rovi is 1.51%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Laboratorios Farmaceuticos Rovi was 3.28%. The lowest was 0.30%. And the median was 1.13%.

Laboratorios Farmaceuticos Rovi's Dividends per Share for the months ended in Dec. 2023 was €0.00.

During the past 12 months, Laboratorios Farmaceuticos Rovi's average Dividends Per Share Growth Rate was 35.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 94.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 77.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 20.40% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Laboratorios Farmaceuticos Rovi was 128.60% per year. The lowest was -16.80% per year. And the median was 4.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.11

0.15

0.14

0.26

0.40

Laboratorios Farmaceuticos Rovi Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	3.58	-	-	-

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio falls into.

Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	1.294	/	3.203
	=	0.40

Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	0.999
	=	0.00

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK 41L:Germany

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.